Cargando…

Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Ruan, Hailong, Li, Sen, Bao, Lin, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816057/ https://www.ncbi.nlm.nih.gov/pubmed/36450864 http://dx.doi.org/10.1038/s41388-022-02534-0

Ejemplares similares

Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
por: Ruan, Hailong, et al.
Publicado: (2020)

Correction to: EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
por: Mao, Linfeng, et al.
Publicado: (2022)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Correction: Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
Publicado: (2021)

Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity
por: Ravasio, Andrea, et al.
Publicado: (2020)

Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity
por: Ravasio, Andrea, et al.
Publicado: (2020)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Author Correction: The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures
por: Singh, Deo R., et al.
Publicado: (2018)

Author Correction: Glucose homeostasis is regulated by pancreatic β-cell cilia via endosomal EphA-processing
por: Volta, Francesco, et al.
Publicado: (2021)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Unliganded EphA3 dimerization promoted by the SAM domain
por: Singh, Deo R., et al.
Publicado: (2015)

Author Correction: Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype
por: Zhang, Ji-chun, et al.
Publicado: (2023)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
por: Buti, Sebastiano, et al.
Publicado: (2018)

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
por: Amin, Asim, et al.
Publicado: (2019)

EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells
por: Cho, Min Chul, et al.
Publicado: (2015)

EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease
por: Vaught, David B, et al.
Publicado: (2021)

Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
por: Cioce, Mario, et al.
Publicado: (2021)

HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis
por: Li, Qi-Guang, et al.
Publicado: (2020)

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
por: Gao, Zicong, et al.
Publicado: (2021)

EphA3 Functions are Regulated by Collaborating Phosphotyrosine Residues
por: Shi, Guanfang, et al.
Publicado: (2010)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021)

EphA7 promotes myogenic differentiation via cell-cell contact
por: Arnold, Laura L, et al.
Publicado: (2020)

Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections
por: Allen-Sharpley, Michelle R., et al.
Publicado: (2013)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Novel [(111)In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2
por: Furukawa, Takenori, et al.
Publicado: (2023)

Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
por: Thundyil, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l53ugvbl5st936acvgmv8o4n28